23.12.2020 22:30:00
|
$95.4 Billion Worldwide Transplantation Industry to 2027 - Impact of COVID-19 on the Market
DUBLIN, Dec. 23, 2020 /PRNewswire/ -- The "Transplantation - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
The publisher brings years of research experience to the 8th edition of this report. The 368-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Global Transplantation Market to Reach $170 Billion by 2027
Amid the COVID-19 crisis, the global market for Transplantation estimated at US$95.4 Billion in the year 2020, is projected to reach a revised size of US$170 Billion by 2027, growing at a CAGR of 8.6% over the period 2020-2027.
Organ transplantation, one of the segments analyzed in the report, is projected to record 10.1% CAGR and reach US$76.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Tissue transplantation segment is readjusted to a revised 7.5% CAGR for the next 7-year period.
The U.S. Market is Estimated at $25.8 Billion, While China is Forecast to Grow at 11.5% CAGR
The Transplantation market in the U.S. is estimated at US$25.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$35.9 Billion by the year 2027 trailing a CAGR of 11.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.7% and 7.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.7% CAGR.
Competitors identified in this market include, among others:
- Abbott Laboratories, Inc.
- Acelity LP, Inc.
- Avioq, Inc.
- AxoGen, Inc.
- BD Biosciences
- BioLife Solutions Inc.
- Bio-Rad Laboratories, Inc.
- CareDx, Inc.
- Carmat SA
- Chronix Biomedical
- Dr. Franz Kohler Chemie GmbH
- F. Hoffmann-La Roche AG
- GenDx
- Histogenics Corporation
- Illumina, Inc.
- Luminex Corporation
- Medipex Limited
- Miromatrix Medical Inc.
- Nano Dimension Ltd.
- Organovo Holdings, Inc.
- Ortho Clinical Diagnostics
- Oxford Immunotec Global PLC
- Pacific Biosciences of California, Inc.
- Pandorum Technologies Pvt. Ltd.
- Qiagen NV
- Siemens Healthineers
- SynCardia
- Thermo Fisher Scientific, Inc.
- Transplant Biomedicals S. L.
- XVIVO Perfusion AB
Key Topics Covered:
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Global Competitor Market Shares
- Transplantation Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
- Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
- Total Companies Profiled: 41
For more information about this report visit https://www.researchandmarkets.com/r/rl2pu6
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
View original content:http://www.prnewswire.com/news-releases/95-4-billion-worldwide-transplantation-industry-to-2027---impact-of-covid-19-on-the-market-301198076.html
SOURCE Research and Markets
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!